Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,226 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06967610RecruitingPhase 2
Pirtobrutinib, venetoclax, and obinutuzumab for recurrent CLL/SLL
This trial tests a combination of three drugs (pirtobrutinib, venetoclax, and obinutuzumab) given for a limited time to people whose CLL/SLL has come back after prior treatment. The goal is to see if this combination can control the cancer and possibly allow a treatment-free period.
Houston, TexasAges 18 years+ - NCT06971874Recruiting
Sleep apnea and kidney disease: A study on outcomes
This trial looks at how obstructive sleep apnea affects people with chronic kidney disease (stages 3-4). It aims to help understand the connection between these conditions and guide better care.
Guangzhou, GuangdongAges 18–75 - NCT06965322Recruiting
Detecting lung problems in rheumatoid arthritis
This study uses CT scans and blood tests to look for lung signs related to rheumatoid arthritis. It aims to find lung issues early, which may help in managing the disease better.
Innsbruck, AustriaAges 18 years+ - NCT06970119RecruitingPhase 1/Phase 2
Study of INR102 for advanced prostate cancer (Phase 1/2)
This trial tests a new investigational drug called INR102 for prostate cancer that has spread and stopped responding to standard treatments. It's given by injection, and the study will check if it's safe and if it can shrink or slow the cancer.
Wuxi, JiangsuAges 18 years+ - NCT06969833Recruiting
Study of Ovarian, Peritoneal, or Fallopian Tube Cancer
This study will collect medical information from people with advanced ovarian, peritoneal, or fallopian tube cancer. The goal is to learn more about these cancers and improve future treatments.
LilleAges 18 years+ - NCT06968611Recruiting
Diabetes and vision care study in Bangladesh
This study tests a program that combines diabetes care with eye exams for people in Bangladesh who were recently diagnosed with diabetes. The goal is to see if this approach helps you better manage your health and prevent vision problems.
DinajpurAges 30 years+ - NCT06966167Recruiting
Laser vs. standard cataract surgery in Fuchs' dystrophy
This study compares two types of cataract surgery in people with Fuchs' dystrophy: one using a laser and the standard method. It looks at which approach gives better results for the cornea and vision.
Shanghai, Shanghai MunicipalityAges 40 years+ - NCT06963723Recruiting
Screening for financial hardship in advanced cancer
This study screens people with advanced cancer for financial problems. It aims to see if catching these problems early can improve your care and well-being.
Phoenix, ArizonaAges 21 years+ - NCT06967467Enrolling by invitation
Testing Penicillin Allergies in Blood Cancer Patients
This study tests if an antibiotic allergy evaluation can help improve treatment for people with blood cancers. It aims to safely remove inaccurate penicillin allergy labels, potentially allowing use of better antibiotics.
Philadelphia, PennsylvaniaAges 18 years+ - NCT06972225Recruiting
Study of heart outcomes after drug-coated balloon treatment
This study looks at heart-related complications in adults who had a coronary angioplasty using a drug-eluting balloon. It aims to understand how well these balloons work over time.
Québec, QuebecAges 18 years+ - NCT06969261Recruiting
Chatbot to support pregnant women with opioid use disorder
This study tests a chatbot to help pregnant and new mothers being treated for opioid use disorder. The goal is to provide extra support and information during and after pregnancy.
Philadelphia, PennsylvaniaAges Any age - NCT06968637Recruiting
Improving diabetes and vision care in Bangladesh
This study tests a new way to combine diabetes care with eye care for people with diabetes in Bangladesh. If you have diabetes and a diabetes-related eye condition, this might help improve your care.
Dinajpur Sadar, DinajpurAges 30 years+ - NCT05205109RecruitingPhase 1
Testing a new melanoma drug alone and with pembrolizumab
This early-stage trial tests ATG 037 to see if it’s safe and how it works in the body, as well as whether it may help people with advanced melanoma. It compares treatment given alone and treatment given together with pembrolizumab, especially in melanoma that has progressed after prior immunotherapy.
Sydney, New South WalesAges 18 years+ - NCT05044403Recruiting
Hemoperfusion for severe sepsis causing multiple organ failure
This study tests whether a blood-filter treatment called hemoperfusion can help critically ill people with sepsis that is not responding to standard shock treatment and is affecting multiple organs. It aims to improve recovery when infections are controlled and inflammation markers are very high.
Castellon, CastellónAges 18–80 - NCT03455868Recruiting
Bone health check after bariatric surgery in people with diabetes
This study looks at how bariatric (weight-loss) surgery affects bone health in adults with type 2 diabetes. It may help doctors understand who needs extra bone protection after surgery.
Montreal, QuebecAges 18–60 - NCT04412616RecruitingPhase 1
Study drug for advanced EGFR-positive solid tumors
This early-phase trial tests a new drug (ZZ06) in adults with advanced solid cancers that have an EGFR “positive” tumor test result. It’s for people whose cancer has grown despite standard treatment or who don’t have a standard option.
Los Angeles, CaliforniaAges 18 years+ - NCT04348838Recruiting
Study of people newly diagnosed with liver cancer in France
This study follows people with hepatocellular carcinoma (HCC), a type of liver cancer, to learn how it changes over time. It may help improve understanding of which patients benefit from different care approaches.
AmiensAges 18 years+ - NCT06346093Recruiting
Fecal transplant for advanced stomach cancer
This trial tests whether a fecal transplant (a stool donation from a healthy person) can help patients with advanced stomach cancer respond better to treatment. If you qualify, you would receive the transplant through a colonoscopy, possibly along with other standard therapies.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06476015Recruiting
Exercise for chronic disease patients
This study looks at whether a physical exercise program can help people with long-term health conditions like COPD or diabetes. If you are 60 to 90 years old and already part of the 'Ser más' program, you may be able to join.
Medellín, AntioquiaAges 60–90 - NCT06857981Recruiting
Prepare for Your Surgery: A Program for Frail Patients
This trial is for people who are frail and planning to have elective surgery in at least 4 weeks. It focuses on a program to help you prepare for your surgery, so you may have a better recovery.
Santiago, Santiago MetropolitanAges 18 years+ - NCT06538077RecruitingPhase 4
BCAA vs. Rifaximin to Prevent Recurrent Hepatic Encephalopathy
This trial compares two treatments—BCAA supplements and rifaximin—to see which is better at preventing another episode of confusion or coma in people with cirrhosis who have already had one. If you qualify, you would receive one of these treatments for several months.
ChandigarhAges 18–65 - NCT06850792Recruiting
Improving treatment adherence with telemedicine and guidance
This study tests whether regular remote check-ins and guidance can help people with pulmonary arterial hypertension stick to their treatment plan. You would be followed by phone or video from University of Sao Paulo.
São Paulo, São PauloAges 18 years+ - NCT06898073Recruiting
Walking and thinking training after stroke
This trial tests whether combining walking on a curved path with doing simple thinking tasks can improve recovery after a stroke. It is for people who can walk at least 10 meters and have some arm and leg movement.
Kaohsiung CityAges 40–80 - NCT06924398RecruitingPhase 2
Post-surgery targeted therapy for remaining lung nodules in EGFR-mutant NSCLC
This trial tests whether a targeted therapy pill (EGFR-TKI) can control small spots in the other lung after surgery for early-stage lung cancer. It's for people whose cancer has a specific EGFR gene change and who still have suspicious spots in the opposite lung after one side is removed.
Guangzhou, GuangdongAges 18–75
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,226 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.